Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.36 USD | -5.63% | +3.08% | +11.40% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.40% | 1.71B | |
+7.77% | 115B | |
+12.91% | 107B | |
-13.56% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.82% | 14.26B | |
+33.01% | 12.37B | |
-27.87% | 8.28B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Insider Trends: Soleno Therapeutics Insider Continues 90-Day Selling Trend